Auven Therapeutics

Finance · Florida, United States · 51-200 Employees

View Company Info for Free

Overview

Headquarters

475 NE 1st St Ste A, Delray Beach, Flori...

Phone Number

(954) 908-2360

Revenue

$6.7 Million

Industry

Finance Venture Capital & Private Equity
ZI Rank: 2
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
2
1
1
1
2

About Auven Therapeutics

Auven Therapeutics is an international private equity firm that acquires and pursues accelerated development of breakthrough drugs prior to licensing to commercial partners. Auven's in-house team of senior pharmaceutical development executives establishes the preclinical, clinical, regulatory, manufacturing and commercial strategies for all its products and oversees their execution. Auven was founded in 2008 by Stephen Evans-Freke and Dr. Peter B. Corr and maintains operations in Lausanne, Ft. Lauderdale, New Jersey, Bermuda, and the U.S. Virgin Islands.Explore more
Auven Therapeutics's Social MediaPopular SearchesAuven Therapeutics' corporationsAuven TherapeuticsAuven Therapeutics Holdings LPAuven Therapeutics Management LLLPAuven Development Company LLCSIC Code 67,679NAICS Code 52,523Show more

Auven Therapeutics Org Chart

PhoneEmail
DK
United States flag for contact location.

Controller

Flame icon indicating likelihood to engage via phone.PhoneFlame icon indicating likelihood to engage via email.Email

PhoneEmail
Get the full picture
Sign in to uncover key details.
JA
United States flag for contact location.

Head of Investor Relations

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Is Auven Therapeutics your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to Auven Therapeutics

Compare insights from companies similar to Auven Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Auven Therapeutics

$6.7M
51-200
Private
-
2007
$123.9M
51-200
Public
$462.1M
1994
TC
Tracy ClementeChief People Officer & Chief Human Resources Officer
$89.5M
51-200
Public
$177.8M
2016
Jingsong Wang, Founder & Chief Executive Officer at Harbour BioMed
Jingsong WangFounder & CEO
$25.4M
11-50
Private
<$5M
2007
$15M
51-200
Private
$181.5M
2015
$7.6M
11-50
Private
-
2019
John Josey, Venture Partner at The Column Group
John JoseyVenture Partner
$5.3M
11-50
Private
$83.5M
2005
Illustration of an envelope

Company Profile Activity

i

Among all Finance companies

Low Activity

High Activity

Activity Insights

Auven Therapeutics is experiencing very low activity levels compared to other companies in the Finance sector.

What does this means?

Auven Therapeutics is drawing exceptional interest within the Finance industry, suggesting notable developments or strong market momentum, learn more about Auven Therapeutics.

Auven Therapeutics Tech Stack

A closer look at the technologies used by Auven Therapeutics

Most Recent Scoops

Project
A high-level source has indicated that the organization has completed initiatives related to learning & development within the last six months.
Learning & Development
Project
A high-level source has indicated that the organization has completed initiatives related to advanced self-service solutions within the last nine months.
Project
A high-level source has indicated that the organization has completed initiatives related to employee self-service (ESS) within the last six months.
HRIS, Employee Engagement
Project
A high-level source has indicated that the organization has completed initiatives related to intellectual property (IP) management within the last nine months.
Enterprise Software, Intellectual Property, Legal Affairs
Project
See more scoops

Auven Therapeutics News & Media

  • ADC Therapeutics Announces Pricing of Underwritten Offering by a Selling Shareholder

    LAUSANNE, Switzerland--(BUSINESS WIRE)--ADC Therapeutics SA (“ADCT” or the “Company”) (NYSE: ADCT), a commercial-stage biotechnology company helping to improve the lives of those affected by cancer with its next-generation, targeted antibody drug conjugates, today announced the pricing of an underwritten offering of 12,000,000 common shares of the Company currently owned by A.T. Holdings II Sàrl (the “Selling Shareholder”), an affiliate of Auven Therapeutics Holdings L.P., at a price of $5.00 p
Read more news

Top Finance Companies

Frequently Asked Questions Regarding Auven Therapeutics

What is Auven Therapeutics's official website?
Auven Therapeutics's official website is www.auventx.com
What is Auven Therapeutics's Revenue?
Auven Therapeutics's revenue is $6.7 Million
What is Auven Therapeutics's SIC code?
Auven Therapeutics's SIC: 67,679
What is Auven Therapeutics's NAICS code?
Auven Therapeutics's NAICS: 52,523
How many employees does Auven Therapeutics have?
Auven Therapeutics has 51-200 employees
What industry does Auven Therapeutics belong to?
Auven Therapeutics is in the industry of: Finance, Venture Capital & Private Equity
What is Auven Therapeutics competition?
Auven Therapeutics top competitors include: Harbour BioMed, Agenus, KSQ Therapeutics, Immunomic Therapeutics
What technology does Auven Therapeutics use?
Some of the popular technologies that Auven Therapeutics uses are: YouTube, Microsoft 365, Vimeo, GoDaddy DNS
How do I contact Auven Therapeutics?
Auven Therapeutics contact info: Phone number: (954) 908-2360 Website: www.auventx.com
What does Auven Therapeutics do?

Auven Therapeutics is an international private equity firm that acquires and pursues accelerated development of breakthrough drugs prior to licensing to commercial partners. Auven's in-house team of senior pharmaceutical development executives establishes the preclinical, clinical, regulatory, manufacturing and commercial strategies for all its pro... ducts and oversees their execution. Auven was founded in 2008 by Stephen Evans-Freke and Dr. Peter B. Corr and maintains operations in Lausanne, Ft. Lauderdale, New Jersey, Bermuda, and the U.S. Virgin Islands.Read More

What are Auven Therapeutics social media links?
Auven Therapeutics Linkedin page
Is Auven Therapeutics a public company?
Auven Therapeutics is private company therefore does not currently have an official ticker symbol
See more information about Auven Therapeutics

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.